Camelia Palici
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Camelia Palici has a total of 7 co-authors. Here are the top co-authors by number of shared publications:
- Alesandra Florescu
Department of Rheumatology, University of Medicine and Pharmacy of Craiova, 200349 Craiova, Romania
1 shared publication - Anca Emanuela Mușetescu
Department of Rheumatology, University of Medicine and Pharmacy of Craiova, 200349 Craiova, Romania
1 shared publication - Andreea Lili Bărbulescu
Department of Pharmacology, Faculty of Medicine, University of Medicine and Pharmacy of Craiova, 200349 Craiova, Romania
1 shared publication - Cristina Elena Bita
Department of Rheumatology, University of Medicine and Pharmacy of Craiova, 2 Petru Rareş Street, 200349 Craiova, Romania
1 shared publication - Florentin Ananu Vreju
Department of Rheumatology, University of Medicine and Pharmacy of Craiova, 200349 Craiova, Romania
1 shared publication - Paulina Lucia Ciurea
Department of Rheumatology, University of Medicine and Pharmacy of Craiova, 200349 Craiova, Romania
1 shared publication
Latest Publications
- Open Access
- 8 July 2024
- Published by MDPI AG in Journal of Personalized Medicine
- Vol. 14 (7) , 734
Skin Ultrasound Assessment of Patients with Systemic Scleroderma—An Observational Study
This study aims to analyze the changes in dermal thickness in patients with systemic scleroderma (SSc) in comparison with normal skin and also compare clinical forms with diffuse and limited cutaneous involvement. The study group consisted of female patients diagnosed with SSc with a disease history not exceeding 5 years. The areas of interest for ultrasound examination included the proximal phalanx of the third finger, the second intermetacarpal space, and the extension surface of the lower third of the forearm. The study included 20 patients diagnosed with SSc and 14 controls. SSc patients were subdivided into two subgroups based on the clinical form. Compared to the control group, patients with SSc had higher mean measurements in all three skin areas, with statistically significant differences in the hand and forearm areas. Patients with diffuse SSc displayed, on average, higher skin thickness compared to limited SSc in all skin areas examined, with a statistically significant difference only in the forearm area. Based on disease manifestations, significant differences were observed only with regard to the presence of pulmonary hypertension in the diffuse SSc group. In conclusion, skin ultrasound is a useful and accessible imaging method for diagnosing and quantifying dermal fibrosis in systemic scleroderma.
- 8 July 2024
- Published by MDPI AG in Journal of Personalized Medicine
- Vol. 14 (7) , 734
Open AccessSkin Ultrasound Assessment of Patients with Systemic Scleroderma—An Observational Study
This study aims to analyze the changes in dermal thickness in patients with systemic scleroderma (SSc) in comparison with normal skin and also compare clinical forms with diffuse and limited cutaneous involvement. The study group consisted of female patients diagnosed with SSc with a disease history not exceeding 5 years. The areas of interest for ultrasound examination included the proximal phalanx of the third finger, the second intermetacarpal space, and the extension surface of the lower third of the forearm. The study included 20 patients diagnosed with SSc and 14 controls. SSc patients were subdivided into two subgroups based on the clinical form. Compared to the control group, patients with SSc had higher mean measurements in all three skin areas, with statistically significant differences in the hand and forearm areas. Patients with diffuse SSc displayed, on average, higher skin thickness compared to limited SSc in all skin areas examined, with a statistically significant difference only in the forearm area. Based on disease manifestations, significant differences were observed only with regard to the presence of pulmonary hypertension in the diffuse SSc group. In conclusion, skin ultrasound is a useful and accessible imaging method for diagnosing and quantifying dermal fibrosis in systemic scleroderma.